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Background/Objectives: Phytoestrogens are naturally occurring estrogen-like compounds commonly
found in foods, especially soybeans and soy products. There have been recent interests as well as evi-
dence in animal studies suggesting that phytoestrogens may protect against cancers, including skin
cancers such as melanoma. To date, no human or epidemiological studies have been performed to
evaluate this association with melanoma. The objective of this study was to investigate the relationship
between tofu consumption, urinary phytoestrogen, and diagnosis of melanoma in a national epidemi-
ologic database.
Methods: Data on the history of melanoma and measured urinary phytoestrogen levels (daidzein, O-
desmethylangolensin, equol, enterodiol, genistein, and enterolactone) from the United States National
Health and Nutrition Examination Survey database from 1999 to 2010 were obtained and analyzed with
univariate and multivariate tests. Using information about tofu consumption and sun-protective be-
haviors, we analyzed the data for the period 2003e2006.
Results: Patients who were older or with higher body mass index (BMI) were signiﬁcantly more likely to
be diagnosed with melanoma in the past [odds ratio (OR) 1.06; 95% conﬁdence interval (CI) 1.05e1.07;
p < 0.001; and OR 1.04; 95% CI 1.02e1.06; p < 0.001, respectively]. Those with a history of melanoma had
lower levels in ﬁve of the six measured creatinine-adjusted urinary phytoestrogens. However, this
relationship was not statistically signiﬁcant after adjusting for confounding factors such as age, sex,
ethnic groups, and BMI. A diet with tofu had a signiﬁcant positive correlation with the levels of measured
urinary phytoestrogens. By contrast, the association between a history of melanoma and such diet did
not achieve statistical signiﬁcance.
Conclusion: In our study, patients with a history of melanoma tend not to consume tofu in their diet and
have lower urinary phytoestrogens levels. The relationship was not statistically signiﬁcant and more
studies need to be carried out.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Melanoma, though accounting for <2% of all skin cancer, is
responsible for the majority of skin cancer mortality.1 For the past
three decades, the incidence of melanoma has been on the rise.1y have no ﬁnancial or non-
atter or materials discussed
1 Mandalay Road 308205,
.W. Yew).
cal Association. Published by ElsevAccording to the American Cancer Society's estimates for 2015,
approximately 73,870 new cases will be diagnosed and 9,940
deaths will be attributed to melanoma in the United States.1 Based
on the 2009e2011 data from the Surveillance, Epidemiology, and
End Results program, the lifetime risk of developing melanoma is
approximately 2.1%.2
Age, ethnicity, high level of exposure to sunlight, history of
sunburn during childhood, and fair skin complexion are important
risk factors for melanoma development.3,4 Among these, exposure
to ultraviolet light has been established as the only recognized
modiﬁable risk factor.5 Hence, chemoprevention of melanoma
would be highly desirable, with exploration of a variety of dietaryier Taiwan LLC. All rights reserved.
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of diet in the chemoprevention of melanoma has always been
controversial and can be challenging for dermatologists during
patient counseling. Antioxidants, in particular, have garnered in-
terests in dermatology in recent years. Plant-derived antioxidants,
such as green tea polyphenols, resveratrol, lycopene, curcumin, as
well as phytoestrogen have been suggested to reduce the risk of
skin cancer.7,8
Phytoestrogens are naturally occurring estrogen-like com-
pounds commonly found in various foods, especially soybeans and
soy products, ﬂaxseed, and sesame seed.9 Recently, phytoestrogen-
containing products have become popular among health-conscious
populations. There have been growing interests in the consumption
of phytoestrogen-containing products as a form of cancer-
preventive supplementation. Recent animal studies indicated that
phytoestrogens can mitigate the oxidative stress and inﬂammation
inherent in many chronic skin diseases and skin cancer.10 Although
there is enough evidence for the protective effects of phytoes-
trogens against skin tumorigenesis in animal models and cell cul-
ture studies,10e15 human studies that evaluate these effects are
lacking. In this study, we aim to investigate whether there is an
association between tofu in the diet, urinary phytoestrogens, and
diagnosis of melanoma using the data from United States (U.S.)
National Health and Nutrition Examination Survey (NHANES)
database.
Methods
Study population
The NHANES is a periodic annual population survey that targets the
civilian, noninstitutionalized U.S. population.16 The major objec-
tives of the survey were to estimate the burden of various common
diseases, trends in risk behaviors, and environmental exposures as
well as to establish any possible relationship between diet, nutri-
tion, and health. It has a stratiﬁed multistage probability sampling
design.16 In our analysis of interest, randomly selected individuals
aged 20e85 years were interviewed about several variables of in-
terest. A total of 59,205 participants subsequently completed lab-
oratory examinations. Data on the history of melanoma diagnosis
and urinary phytoestrogens levels in the cycle years from 1999 to
2010 were retrieved and analyzed retrospectively.
Outcome
Diagnoses of melanoma were identiﬁed from the 1999e2010
NHANES “Medical Condition” section of the questionnaire data.
Study participants were asked to report if theywere ever diagnosed
with melanoma. Information on the age at which melanoma was
ﬁrst diagnosed was also recorded.
Laboratory and questionnaire data variables
The measured urinary phytoestrogens levels included genistein,
daidzein, O-desmethylangolensin (O-DMA), equol, enterodiol, and
enterolactone. Urine samples were processed using enzymatic
deconjugation of the glucuronidated phytoestrogens, followed by
solid-phase extraction.17 Subsequently, the quantiﬁcation of these
phytoestrogens in the urine was performed using the high-
performance liquid chromatographyeelectrospray ionization-
tandem mass spectrometry method.17 These urinary phytoestro-
gen metabolites were measured using random spot urine speci-
mens, which were susceptible to intraindividual variability. To
compensate for this variability, urinary phytoestrogen levels were
divided by individuals' spot urinary creatinine level to yieldcreatinine-adjusted values. Variables such as age, sex, ethnic
groups, and body mass index (BMI) were included for analysis as
possible confounding factors.
To clearly deﬁne the relationship between dietary phytoes-
trogens and melanoma as well as to explore the impact of potential
confounding factors, an analysis of the data from 2003 to 2006 was
conducted. In NHANES, detailed dietary records documenting tofu
consumption and questions regarding sun-protective behaviors
were only available in the cycle years from 2003 to 2006. Data
regarding tofu consumptions were collected by asking if partici-
pants had tofu, soy burgers, or soy meat substitutes in their usual
diet for at least the past 12 months. Those who reported con-
sumption for at least once a week were considered to have a sig-
niﬁcant intake of phytoestrogens in their diet.
All results were adjusted for melanoma-related confounding
variables such as age, sex, ethnic groups, sun-protective behaviors,
and BMI using multivariate logistic regression. Sun-protective be-
haviors investigated in the survey questionnaire included staying in
the shade, wearing suitable hats, wearing long sleeves as well as
applying sunscreens. In this analysis, participants who engaged in
one of the aforementioned sun-protective behaviors most of the
time were deemed to have regular sun-protective behaviors.
Data analysis
Using independent sample t test and ManneWhitney U test,
creatinine-adjusted urinary phytoestrogen levels were compared
between those with melanoma and those without melanoma.
Univariate and multivariate logistic regression analyses were per-
formed to calculate the crude odds ratio (OR) as well as adjusted
ORs of the relationship, taking into account the aforementioned
confounding factors. Both independent sample t test and Man-
neWhitney U test were performed to assess the relationship be-
tween tofu consumption and levels of creatinine-adjusted urinary
phytoestrogens. Dietary patterns of tofu consumption between
those with and without melanomawere analyzed using Chi-square
test or Fisher's exact test.
SPSS (version 22; IBM, Armonk, NY, USA) was used for the
analysis of the abovementioned variables to evaluate statistical
signiﬁcance. OR, 95% conﬁdence interval (CI), and p values were
calculated to test the null hypotheses of the association between
tofu consumption/urinary phytoestrogens and melanoma. A two-
sided p < 0.05 was considered statistically signiﬁcant.
Clinical information and laboratory data on the 1999e2010
NHANES cycles were available from the publicly accessible U.S.
Centers for Disease Control and Prevention database. The NHANES
was approved by the U.S. National Center for Health Statistics Ethics
Review Board and documented consent was obtained from all
participants.
Results
A total of 59,205 participants from the NHANES database from 1999
to 2010 were included in the analysis. There were 172 reported
cases of melanoma. The median age of diagnosis was 59 years. The
median time of diagnosis was 8 years prior to the survey. Patients
who had a history of melanomawere signiﬁcantly older than those
without (OR 1.06; 95% CI 1.05e1.07; p < 0.001). Of these 172 mel-
anoma cases, 90 were men and 82 were women (p ¼ 0.402). The
median BMI of those who had a history of melanoma was 26.9 kg/
m2. Patients who had a history of melanoma had a signiﬁcantly
higher BMI compared with those without (OR 1.04; 95% CI
1.02e1.06; p < 0.001).
Urinary phytoestrogen data were available for 15,688 partici-
pants during the survey period from 1999 to 2010. Of these, there
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of the six measured creatinine-adjusted urinary phytoestrogens
(daidzein, O-DMA, equol, enterodiol, and genistein) were associ-
ated with lower odds, albeit not statistically signiﬁcant, of being
diagnosed with melanoma (Table 1). Multivariate logistic regres-
sion analysis with confounding variables such as age, sex, ethnic
groups, and BMI also failed to yield any signiﬁcant relationship.
As shown in Table 2, compared with those without melanoma,
study participants with a history of melanoma had lower levels in
ﬁve of the six creatinine-adjusted urinary phytoestrogens. How-
ever, none of the results reached statistical signiﬁcance under both
two-sample t test and ManneWhitney U test.
In the analysis of data from 2003 to 2006, there were 19,467
study participants and 57 cases of melanoma. The underlying de-
mographics characteristics were comparable to the overall study
population. Detailed dietary patterns were available for 4225 study
participants, and among them 884 had tofu in their diet. Of the
19,467 study participants who responded to the questions on sun-
protective behaviors, 28.5% reported engaging in at least one of the
four sun-protective behaviors listed in the questionnaire (staying in
the shade, wearing suitable hats, wearing long sleeves, and
applying sunscreens).
Dietary records documenting tofu consumption were analyzed
to evaluate whether they correlated with the six measured
creatinine-adjusted urinary phytoestrogens levels. As shown in
Table 3, those who consumed tofu in their diet had signiﬁcantly
higher creatinine-adjusted urinary phytoestrogens, compared with
those who did not consume any soy products. Although those who
consumed tofu had decreased odds of being diagnosed with mel-
anoma, the results did not reach statistical signiﬁcance, even after
adjusting for potential confounding factors such as age, sex, ethnic
groups, BMI, and sun-protective behaviors (Table 4).
Discussion
Phytoestrogens are plant-based compounds that structurally
resemble endogenous estrogens.9 There are three major types of
phytoestrogens, namely, lignans, isoﬂavones, and coumestans.9
Among these, lignans (enterolactone and enterodiol) and iso-
ﬂavones (genistein and daidzein) are frequently found in human
diets.18 The main site of phytoestrogen metabolism is the gastro-
intestinal tract, which results in the formation of heterocyclicTable 1 Univariate and multivariate logistic regression analyses of variables and history
Variables Univariate
Crude OR OR 95% CI
Creatinine-adjusted urinary phytoestrogens (mg/gCr)
Genistein (n ¼ 15,688) 0.971 0.881e1.069
Daidzein (n ¼ 15,684) 0.986 0.941e1.032
ODMA (n ¼ 15,389) 0.926 0.737e1.165
Equol (n ¼ 15,308) 0.783 0.367e1.674
Enterodiol (n ¼ 15,658) 0.999 0.949e1.052
Enterolactone (n ¼ 15,679) 1.002 0.994e1.010
Age (n ¼ 59,205), y 1.063 1.054e1.072
Sex (n ¼ 59,205)
Male 1.139 0.844e1.537
Female 1.000 d
Ethnic groups (n ¼ 59,205)
Mexican American 0.038 0.014e0.104
Other Hispanic 0.037 0.005e0.263
Non-Hispanic black 0.031 0.010e0.097
Other race 0.052 0.007e0.373
Non-Hispanic white 1.000
BMI (n ¼ 53,381), kg/m2 1.038 1.020e1.056
BMI ¼ body mass index; CI ¼ conﬁdence interval; NHANES ¼ National Health and Nutr
a Adjusted for age, sex ethnic groups, and BMI.phenols.19 After ingestion, daidzein is further metabolized by in-
testinal bacteria to equol and O-DMA. In addition, absorbed phy-
toestrogens undergo enterohepatic circulation and are mostly
excreted in the urine.19
Because of the presence of a phenolic ring that allows for
binding to the estrogen receptor, phytoestrogens can either act as
weak agonists, partial agonists, or as antagonists at estrogen re-
ceptors.20 It is interesting to note that equol, but not O-DMA, has
estrogenic activity.19 As a result of their estrogenic activities, there
have been concerns that exposure to phytoestrogen may induce or
exacerbate hormone-related cancers. A systemic review of current
literature, however, had demonstrated that soy consumption may
be associated with decreased risk of breast cancer.21 A recent meta-
analysis demonstrated that, in men at risk, phytoestrogens resulted
in signiﬁcant reduction in the diagnosis of prostate cancer.22 Other
epidemiological studies, though inconclusive, also suggested that
phytoestrogens may decrease the risks of lung, gastric, pancreatic,
colorectal, and ovarian cancers.9 This might be due to the anti-
proliferative and antiangiogenic effects of phytoestrogens.9 Thus
far, there have only been animal studies investigating localized
effect of topical phytoestrogens on skin tumorigenesis. It is still
unclear how the systemic levels of phytoestrogens would translate
into the local effect on the skin. Although knowledge on the most
ideal method to measure phytoestrogen levels in the body is lack-
ing, urinary levels of daidzein, genistein, and enterolactone have
been shown to be good biomarkers of dietary intake.23
In our study, the creatinine-adjusted levels of urinary phytoes-
trogens seemed to be inversely associated with the history of
melanoma. Although this relationship does not reach statistical
signiﬁcance, it suggests that there might be an association between
intake of phytoestrogens and a decrease in development of mela-
noma. Multivariate analysis with known confounding factors such
as age, sex, ethnic groups, and BMI yielded a similar relationship.
Those with higher levels of urinary phytoestrogens have up to 1.2
times the odds of not having a history of melanoma. Other potential
confounding factors such as family history of melanoma, skin types,
or sun-protective behaviors were not available for the period
1999e2010 for multivariate analysis.
The analysis from 2003 to 2006 speciﬁcally examined the rela-
tionship between tofu consumption andmelanoma. The creatinine-
adjusted urinary phytoestrogens levels correlated signiﬁcantly with
consumption of phytoestrogen-containing products such as tofu.of melanoma in NHANES from 1999 to 2010.
p Multivariate p
Adjusted ORa OR 95% CI
0.546 0.965 0.867e1.073 0.508
0.538 0.990 0.947e1.035 0.656
0.513 0.923 0.739e1.153 0.480
0.528 0.690 0.239e1.998 0.690
0.976 0.985 0.899e1.078 0.741
0.621 0.995 0.973e1.017 0.653
<0.001 d d d
0.395 d d d
d d d d
d d d
<0.001 d d d
0.001 d d d
<0.001 d d d
0.003 d d d
<0.001 d d d
ition Examination Survey; ODMA ¼ O-desmethylangolensin; OR ¼ odds ratio.
Table 2 Correlation of creatinine-adjusted urinary phytoestrogens with a history of melanoma in NHANES from 1999 to 2010.
Mean creatinine-adjusted urinary phytoestrogens (mg/gCr) History of melanoma t statistic p*
Yes No
Genistein (n ¼ 15,688) 97.63 148.11 0.554 0.579
Daidzein (n ¼ 15,684) 214.47 329.44 0.558 0.577
ODMA (n ¼ 15,389) 32.65 72.09 0.534 0.593
Equol (n ¼ 15,308) 13.61 46.62 0.507 0.612
Enterodiol (n ¼ 15,658) 101.89 104.38 0.030 0.976
Enterolactone (n ¼ 15,679) 790.85 664.89 0.506 0.613
* Two-sample independent t test.
NHANES ¼ National Health and Nutrition Examination Survey; ODMA ¼ O-desmethylangolensin.
Table 3 Correlation of creatinine-adjusted urinary phytoestrogens and their relationship with dietary soy milk and tofu in NHANES from 2003 to 2006.
Mean creatinine-adjusted urinary phytoestrogens (mg/gCr) Tofu in the diet t statistic p*
Yes No
Genistein (n ¼ 1422) 238.61 92.07 2.919 0.004
Daidzein (n ¼ 1422) 459.90 199.92 2.979 0.003
ODMA (n ¼ 1412) 135.49 42.91 2.778 0.006
Equol (n ¼ 1420) 148.08 34.34 1.604 0.110
Enterodiol (n ¼ 1422) 179.02 110.42 2.812 0.005
Enterolactone (n ¼ 1422) 1267.79 698.45 2.699 0.007
* Two-sample independent t test.
NHANES ¼ National Health and Nutrition Examination Survey; ODMA ¼ O-desmethylangolensin.
Table 4 Univariate and multivariate logistic regression analyses of variables and a history of melanoma in NHANES from 2003 to 2006.
Characteristics History of melanoma? Univariate analysis p Multivariate analysis p
Crude OR Adjusted ORaYes No
Tofu in diet (n ¼ 4225)
Yes 2 882 0.686 0.625 0.667 0.615
No 11 3330 1.000 1.000
Age (n ¼ 6549), y 35.71 37.58 0.985 0.493 1.001 0.980
Sex (n ¼ 6549)
Male 4 3078 0.345 0.063 0.114 0.038
Female 13 3454 1.000 1.000
Ethnic groups (n ¼ 6549)
Mexican American 5 1372 1.862 0.305 1.982 0.378
Other Hispanic 1 250 2.043 0.509 3.177 0.305
Non-Hispanic black 4 1542 1.343 0.648 1.916 0.404
Other race 1 324 1.577 0.674 2.609 0.400
Non-Hispanic white 6 3065 1.000 e 1.000 e
Sun-protective behaviors (n ¼ 6549)
Yes 14 5538 0.838 0.735 0.723 0.679
No 3 994 1.000 1.000
BMI (n ¼ 6195), kg/m2 27.07 28.71 0.959 0.349 0.949 0.277
BMI ¼ body mass index; NHANES ¼ National Health and Nutrition Examination Survey; OR ¼ odds ratio.
a Adjusted for age, sex, ethnic groups, sun-protective behaviors, and BMI.
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be expected tohavehigher phytoestrogenmetabolites in their urine.
However, no signiﬁcant association was observed between the
consumption of tofu and history of melanoma, even after adjusting
for known risk factors for melanoma such as age, sex, BMI, ethnic
groups, and Sun-protective behaviors. Although soy products such
as tofu contained the highest concentration of phytoestrogens in the
forms of genistein and daidzein, the relationship between phy-
toestrogens and melanoma might be underestimated because in-
formation on the intake of other well-recognized phytoestrogen-
containing foods such as ﬂaxseeds or sesame seeds was not avail-
able. Binary analysis of dietary phytoestrogens might also be too
simpliﬁed to describe the relationship.
Studies utilizing different animal models have elucidated
various potential pathways through which phytoestrogens may
exert their photoprotective and antitumor effects. Genistein is
postulated to protect against the development of melanoma byinhibiting UVB-induced epidermal growth factor and mitogen-
activated protein kinase phosphorylation, which promote cell
proliferation and photocarcinogenesis.24 It also increases melanin
production and tyrosinase activity to protect melanocytes from
UVB radiation.25
The common food groups in Western diet that are rich in phy-
toestrogen include nuts and oilseeds, soy products, cereals and
breads, legumes, meat products, and other processed foods that
may contain soy, vegetables, or fruits.26 The highest concentration
of total isoﬂavones is found in soy products, followed by legumes,
meat products, cereals and breads, nuts and oilseeds, vegetables,
and ﬁnally fruits.26 Soybeans, ﬂaxseed, sesame seed, and any
products that contain them have the highest amount of total phy-
toestrogens.27 Most of these foods provide an important source of
proteins and are generally healthy. Therefore, such food can be
encouraged as part of a general healthy diet regime in patients with
risk factors for melanoma or nonmelanoma skin cancers.
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signiﬁcantly less prevalent among non-Hispanic whites, who were
also signiﬁcantly more likely to have a history of melanoma.
Although this could be related to their Fitzpatrick skin types, which
predisposed them to frequent sunburns, other biological factors28
and different dietary/lifestyle habits among the various ethnic
groups might also play a role. However, because fair skin
complexion and a history of sunburns are well-established risk
factors for melanoma, a focus on lifestyle modiﬁcations such as sun
avoidance and sun-protective practices should still remain as the
primary preventive strategy for reducing the incidence of
melanoma.
One of the strengths of this study was that it conglomerated
data from a comprehensive database collected over a decade. In
addition, corrected urinary phytoestrogen levels based on urinary
creatinine levels were used to account for interindividual/intra-
individual variability in the absorption and metabolism of phyto-
estrogen. The main limitation was the potential inaccuracy in
dietary data collection. Dietary habits were also likely to ﬂuctuate
throughout a person's life. Furthermore, it was difﬁcult to quantify
the exact amount of phytoestrogens in a person's diet. Another
limitation was that urinary phytoestrogens levels were measured
during the study, while the diagnosis melanoma was made prior to
the study, with a median time of 8 years. As a result, a causal
relationship between phytoestrogens and the occurrence of mela-
noma cannot be established. In addition, a comprehensive docu-
mentation of foods rich in lignans, such as ﬂaxseeds and sesame
seeds, was not available in the dietary questionnaire, precluding
evaluation of the association between lignans and melanoma. Data
on family history of melanoma and Fitzpatrick skin types were also
not available. Only the data from 2003 to 2006 included informa-
tion about certain phytoestrogen-containing foods and important
melanoma risk factors such as sun-protective behavior.
In conclusion, those with a history of melanoma in our study
had a consistently lower amount of phytoestrogen in their diet and
urine. However, given the limitations of our study design and a lack
of signiﬁcant results, there is still insufﬁcient evidence to support
the protective effect of phytoestrogens. With animal studies
providing increasing evidence for phytoestrogens as important
agents in mitigating skin tumorigenesis, more epidemiological
studies would be needed. A prospective cohort study would be
ideal to further evaluate the association between phytoestrogen
intake and melanoma incidence.
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